Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free public preview Track SLDB with free AI briefings, catalyst countdowns, and dilution alerts.

SLDB

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$159.4M Cash on Hand
9.6mo Cash Runway
18.5% Short Interest

🧪 Upcoming Trial Catalysts

📊 Drug Pipeline

DrugIndicationPhaseStatus
SGT-003 Duchenne Muscular Dystrophy PHASE3 RECRUITING
SGT-212 Friedreich's Ataxia (FA) PHASE1 RECRUITING
SGT-501 Catecholaminergic Polymorphic Ventricular Tachycar PHASE1 RECRUITING

💰 Cash Runway & Dilution Risk

SLDB holds $159.4M in cash and burns about $49.9M/quarter from operations, giving an estimated runway of 9.6 months. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for SLDB free →

📈 Recent Insider Activity (Form 4)

DateInsiderTypeValue
2026-07-07 SMITH IAN F
Purchase $0
2026-07-07 SMITH IAN F
Sale $0
2026-06-11 EDELMAN JOSEPH
Purchase $0
2026-06-11 SMITH IAN F
Purchase $0
2026-06-11 Nagendran Sukumar
Purchase $0

Get the full SLDB picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for SLDB and 2 more tickers of your choice.

Create Free Account →
Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.